Covid vax cash cow gets fatter

Posted 20 October 2021 PM

After unprecedented vaccine sales this year, mRNA vaccines are set to dominate the market even more next year.

According to a new analysis, Pfizer and Moderna are predicted to rake in a combined US$93.2 billion between them, almost double the amount this year and over three-quarters of the projected total vaccine market of $124 billion. The projection by health data analytics firm Airfinity, was reported in the Financial Times this week.

To see the whole article, please login